Dulaglutide Versus Insulin in Adolescents With Thalassaemia-Induced Diabetes: Improving Glycaemic Control and Metabolic Health in a High-Risk Population
The DIADEMA trial demonstrates dulaglutide's superiority over insulin in improving glycaemic variability, pancreatic function, and iron overload, without safety concerns, in adolescents with thalassaemia-induced diabetes.
